enGene Holdings Inc. (ENGN) vs Health Catalyst, Inc. (HCAT)
A side-by-side comparison of enGene Holdings Inc. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.84HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
HCAT
Health Catalyst, Inc.
$1.78HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
Total return — ENGN vs HCAT
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)HCAT -75.7% (-37.6%/yr)HCAT compounded faster over this window
ENGN HCAT
ENGN vs HCAT: by the numbers
- •HCAT is the larger company ($131M vs $123M market cap).
- •Both run net losses; ENGN's is the smaller (0.00% vs -90.61% net margin).
Metrics side by side
Valuation
| Metric | ENGN | HCAT |
|---|---|---|
| P/S ratio | N/A | 0.45 |
| P/B ratio | 0.53 | 1.30 |
| EV / EBITDA | N/A | 74.50 |
| FCF yield | N/A | 9.96% |
Profitability
| Metric | ENGN | HCAT |
|---|---|---|
| Gross margin | 0.00% | 33.47% |
| Operating margin | 0.00% | -11.60% |
| Net margin | 0.00% | -90.61% |
| ROE | -2.13% | -262.64% |
| ROIC | -1.78% | -21.42% |
Growth (annualized)
| Metric | ENGN | HCAT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.24% |
| Total return CAGR (5Y) | N/A | -48.35% |
Go deeper
Dig into the metrics
enGene ROEHealth Catalyst ROEenGene operating marginHealth Catalyst operating marginenGene revenue growthHealth Catalyst revenue growthenGene free cash flowHealth Catalyst free cash flow
enGene & Health Catalyst appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.